Square Pharmaceuticals (DHA:SQURPHARMA) Total Stockholders Equity : BDT134,686 Mil (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Square Pharmaceuticals Total Stockholders Equity?

Square Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Mar. 2025 was BDT134,686 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Square Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2025 was BDT151.94. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Square Pharmaceuticals's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.01.

Square Pharmaceuticals Total Stockholders Equity Historical Data

The historical data trend for Square Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Square Pharmaceuticals Total Stockholders Equity Chart

Square Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Stockholders Equity

Get a 7-Day Free Trial

77,305.84

92,663.78

105,202.56

115,195.94

125,919.30

Square Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															121,786.90	125,919.30	132,757.31	128,997.02	134,685.80

Square Pharmaceuticals (DHA:SQURPHARMA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Square Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(134685.802	-	0)	/	886.451
	=	151.94

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Square Pharmaceuticals's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(622.236	+	355.559)	/	134685.802
	=	0.01

Square Pharmaceuticals Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Square Pharmaceuticals's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Square Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Square Pharmaceuticals PLC (DHA:SQURPHARMA) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

Square Centre, 48, Mohakhali Commercial Area, Dhaka, BGD, 1212

Website

https://www.squarepharma.com.bd

Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals products, Basic chemical products, and animal health products. The company operates in one segment, which is the business of developing, manufacturing, and marketing drugs for health care for all living species. It manufactures drugs like paracetamol, clotrimazole, antiallergic, Nitroglycerin, xylometazoline HCl, erythromycin, and various other drugs. Company also provides devices such as AnsuPen and AnsuPen Twist. The company operates in Bangladesh and sells its products locally and internationally.

Square Pharmaceuticals Headlines

No Headlines